XML 15 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Revenue
Expenses:        
Cost of sales
Research and development 53,833 1,819 81,076
Selling, general and administrative 25,984 32,253 89,850 111,700
Total expenses 25,984 86,086 91,669 192,776
Loss from operations (25,984) (86,086) (91,669) (192,776)
Other income (expense)        
Interest income (expense)
Net loss $ (25,984) $ (86,086) $ (91,669) $ (192,776)
Net loss per share - basic and diluted (in dollars per share) $ 0 $ 0 $ 0 $ 0
Weighted-average number of common shares outstanding - basic and diluted (in shares) 45,572,568 45,572,568 45,572,568 45,572,568